Quality & InnovationExclusively Foot and Ankle
Quality & InnovationExclusively Foot and Ankle
Just LaunchedMobile Lab - Foot & Ankle Surgeon Education Brought to You
Paragon 28’s new mobile lab is housed in a 43x30 foot tractor-trailer which includes a state-of-the-art, 6-station, cadaveric training facility accommodating up to 20 surgeons. The mobile lab will host over 50 training sessions in approximately fifty US cities during the second half of 2022.
The Future of Foot & AnkleIntroducing: SMART28℠
Tailored for the unique demands of foot and ankle treatments, SMART28℠ delivers anatomy-specific modules, patient-centric planning, and a streamlined Case Management Portal, connecting surgeons with powerful, data-driven insights.
With artificial intelligence, data analytics, patient specific algorithms, and 3D modeling, SMART28℠ equips surgeons with precision tools designed for enhanced surgical planning and patient outcomes.
With artificial intelligence, data analytics, patient specific algorithms, and 3D modeling, SMART28℠ equips surgeons with precision tools designed for enhanced surgical planning and patient outcomes.
COMPREHENSIVE SYSTEMS
Advancing the Science of Foot & Ankle Surgery
- Trauma Solutions
- HAV
- Ankle Fusion
- Biologics
Ankle FractureGorilla® Ankle Fracture Plating System
Calcaneal FractureGorilla® Calc Fracture Plating System
Lisfranc FractureGorilla® Lisfranc Plating System
Bunion SystemPhantom® MIS System
Bunion SystemPhantom® Intramedullary Nail
Bunion SystemsLapidus Cut Guide System
Nail SystemsPhantom ActivCore™ Nail
Plating SystemsSilverback™ Ankle Fusion Plating System
Nail SystemsPhantom® Hindfoot TTC/TC System
Bone HealingBEAST™ Demineralized Bone Matrices
Bone HealingMgnum™ BVF
Wound CarePRESERVE™ ParaDerm® Dermal Matrix
Surgeon Testimonials
Zimmer Biomet Completes Acquisition of Paragon 28
WARSAW, Ind., April 21, 2025 — Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”; NYSE and SIX: ZBH), a global medical technology leader, today announced it has completed the acquisition of Paragon 28, Inc. (“Paragon 28”), a leading medical device company focused exclusively on the fast-growing foot and ankle orthopedic space. “We look forward to building on the strong foundation set by...
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28
(WARSAW, Ind. and ENGLEWOOD, Colo.) January 28, 2025 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle orthopedic segment, today announced they have entered into a definitive agreement for Zimmer Biomet to...
Paragon 28 Launches the Phantom® Fibula Nail System for Less Invasive Fracture Repair
ENGLEWOOD, Colo.– Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of the Phantom® Fibula Nail System, designed to give surgeons a less invasive option to treat the fibula when patients sustain an ankle fracture. Use of a fibula nail for the treatment of ankle fractures has been shown to have significantly fewer...
LINKS
CALL US
The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.
© 2025 Paragon 28, Inc.